Enzastaurin
SIGMA/SML0762 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 170364-57-5
Empirical Formula (Hill Notation): C32H29N5O2
Molecular Weight: 515.60
Linear Formula: C32H29N5O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | , light orange to dark orange-red |
| form | powder |
| InChI | 1S/C32H29N5O2/c1-35-19-25 |
| InChI key | AXRCEOKUDYDWLF-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | N1C(=O)C(=C(C1=O)c6c7c([n |
| solubility | DMSO: 10 mg/mL, clear (warmed) |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Enzastaurin has been used in splicing analysis to study its effects on splicing of a mutated exon. |
| Biochem/physiol Actions: | Enzastaurin is a potent and PKCβ preferring inhibitor. Also, Enzastaurin inhibits AKT and GSK3β. Enzastaurin acts as anti-angiogenic and antineoplastic agent. |
| Biochem/physiol Actions: | Enzastaurin is a potent and PKCβ proffering inhibitor. |
| Biochem/physiol Actions: | It is an orally administered drug. It can induce apoptosis, inhibit angiogenesis and proliferation of cells. Enzastaurin can be used for the treatment of haematological cancers. |
| Features and Benefits: | This compound is featured on the GSK-3 , PKB/Akt and PKC pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H413 |
| Precautionary statements | P273 - P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


